Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:4.1.2.13 (
aldolase
)
3,461
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The masses of inositol phosphates have been determined in isolated skeletal muscles from Xenopus laevis (sartorius, tibialis anterior and iliofibularis) and rat (gastrocnemius and soleus) which were quick-frozen in the resting state and at different stages of an isometric (Xenopus) or isotonic (rat) tetanus. The isomeric spectrum of inositol phosphates detected was similar to that in other tissues and cell types. The total sarcoplasmic concentrations of the isomers Ins-(1,4,5,6)P4/Ins(3,4,5,6)P4 (0.2-0.9 microM), Ins(1,3,4,6)P4 (not detectable), Ins(1,3,4,5,6)P5 (about 1 microM) and InsP6 (3.2-4.6 microM) were lower than in other cell types. Variations in these concentrations were due to the muscle type rather than to the donor species. The putative second messenger
Ins(1,4,5)P3
, as well as its dephosphorylation product Ins(1,4)P2, were present at surprisingly high total myoplasmic resting concentrations, ranging from 1.2 to 2.5 microM and 3.5 to 6.9 microM respectively. Upon tetanic stimulation these two inositol phosphates in particular exhibited significantly increased total sarcoplasmic concentrations, up to 4.2 microM and 11.3 microM respectively, with a time scale of seconds. From the initial rate of increase in the total sarcoplasmic concentrations of
Ins(1,4,5)P3
and its rapidly formed metabolic products, a minimal phosphoinositidase C (PIC) activity in tetanically activated Xenopus skeletal muscle of about 1.7-2.6 microM/s can be estimated. This PIC activity observed in vivo seems to be far too low to account for a functional role for
Ins(1,4,5)P3
as a chemical transmitter in the fast excitation-contraction coupling (ECC) process in skeletal muscle. The presence of Ins(1,3,4,5)P4 in all muscle types is indicative of a Ca(2+)-activated Ins(1,4,5)P3 3-kinase activity. The rapid transient increases in Ins(1,3,4)P3 and Ins(1,3)P2 in isometrically contracting Xenopus muscles suggest that corresponding Ins(1,3,4,5)P4 phosphatases are operating in skeletal muscle as well. In all muscles investigated except rat soleus, the fructose 1,6-bisphosphate [Fru(1,6)P2] concentration increased substantially during a tetanus, up to about 2 mM. This increase is correlated with a simultaneous decrease in phosphocreatine, whereas the energy charge of the muscles was essentially unaffected by the applied tetani. The time course of the rise in Fru(1,6)P2 was used to model changes in the free concentrations of high-affinity
aldolase
-binding inositol phosphates during the course of a tetanus. These calculations demonstrate that the free concentration of
Ins(1,4,5)P3
and other
aldolase
-bound inositol phosphates can increase much faster and to a larger extent than the corresponding total concentrations as a result of their competitive displacement from
aldolase
-binding sites by the rapidly rising concentration of Fru(1,6)P2.
...
PMID:Masses of inositol phosphates in resting and tetanically stimulated vertebrate skeletal muscles. 176 26
Skeletal muscle triads are possessing the whole set of enzymes of the phosphatidylinositol (PI)-linked signal generating pathway, PI-kinase, PI(4)P-kinase, and PI(4,5)P2-phospholipase C (PLC). The activities of these enzymes are comparable to those found in other cell types for which a functional role of the PI-pathway in intracellular signal transduction has been established. For skeletal muscle an unequivocal function and an initiating signal for
Ins(1,4,5)P3
-liberation is still unknown. However, the observed Ca-dependency of PLC activity suggests that here
Ins(1,4,5)P3
production is a consequence rather than a cause of increasing cytosolic Ca2+. Recently, the glycolytic enzyme
aldolase
, whose activity can be modulated by inositol polyphosphates, has been localized in the triadic structure. The enzyme which has a high affinity to Ins(1,4)P2,
Ins(1,4,5)P3
and Ins(1,3,4,5)P4, seems to be compartmentalized to the junctional foot structure from which it is released upon binding of these molecules. This phenomenon could reflect a capability for regulation of the glycolytic flux even for
aldolase
, especially if a non steady-state situation in the junctional gap is considered. Meanwhile we have accumulated evidence for the operation of a partial glycolytic sequence in the junctional region established by the enzymes
aldolase
, glyceraldehyde-3-P (GAP) dehydrogenase and phosphoglycerate kinase. This system is able to produce ATP upon oxidation of GAP and could be, because of the inositol polyphosphate-sensing abilities of
aldolase
, a target for the membrane associated PI-pathway. The ATP production is however transient which indicates the coupling to an ATP hydrolyzing reaction.(ABSTRACT TRUNCATED AT 250 WORDS)
...
PMID:Relation of phosphatidylinositol metabolism to glycolytic pathway in skeletal muscle membranes. 228 42
The effects of inositol 1,4,5-trisphosphate (
Ins(1,4,5)P3
), which has been hypothesized to be a chemical transmitter in excitation-contraction coupling in skeletal muscle, on
aldolase
bound to isolated triad junctions were investigated. Fructose-1,6-bisphosphate
aldolase
was identified as the major specific binding protein for the
Ins(1,4,5)P3
analogue glycolaldehyde (2)-1-phospho-D-myo-inositol 4,5-bisphosphate which can form covalent bonds with protein amino groups by reduction of the Schiff's base intermediate with [3H]NaCNBH3. This analogue, Ins(1,4,5) P3, and the inositol polyphosphates inositol 1,3,4,5-tetrakisphosphate and inositol 1,4-bisphosphate were nearly equipotent in selectively releasing membrane bound
aldolase
with a K0.5 of about 3 microM. The rank order of the K0.5 values was identical to the KI values for inhibition of
aldolase
. Aldolase was also released by its substrate fructose 1,6-bisphosphate and by 2,3-bisphosphoglycerate.
Ins(1,4,5)P3
-induced
aldolase
release did not disrupt the triad junction; glyceraldehyde-3-phosphate dehydrogenase, a known junctional constituent, was displaced only at much higher
Ins(1,4,5)P3
concentrations.
Ins(1,4,5)P3
was as effective as fructose 1,6-bisphosphate in releasing
aldolase
from myofibrils. A finite number of binding sites for
aldolase
exist on triads (Bmax = 43-47 pmol of tetrameric
aldolase
exist on triads (Bmax = 43-47 pmol of tetrameric
aldolase
/mg of triad protein, KD = 23 nM). The junctional foot protein was implicated as an
aldolase
binding site by affinity chromatography with the junctional foot protein immobilized on Sepharose 4B. The potential consequences of
aldolase
being bound in the gap between the terminal cisternae and the transverse tubule to inositol polyphosphate and glycolytic metabolism in that local region are discussed.
...
PMID:Inositol polyphosphate-mediated repartitioning of aldolase in skeletal muscle triads and myofibrils. 278 11
A cytoskeletal fraction of porcine tracheal smooth muscle (PTSM) was found to contain > 90% of total cellular
aldolase
(fructose 1,6-bisphosphate
aldolase
,
EC 4.1.2.13
) activity. PTSM
aldolase
was purified by DEAE and inositol 1,4,5-trisphosphate (
Ins(1,4,5)P3
) affinity chromatography and found to react with an antibody directed against human aldolase C, but not anti-aldolase A and B. The molecular mass of native
aldolase
was about 138 kDa (on Sephacryl S-300); SDS-denatured enzyme was 35 kDa (comigrated with rabbit skeletal muscle
aldolase
). Total cellular
aldolase
tetramer (aldolase4) content was 34.5 pmol/100 nmol lipid P(i).
Ins(1,4,5)P3
) binding activity coeluted with
aldolase
during Sephacryl 300, DEAE, and
Ins(1,4,5)P3
affinity chromatography.
Ins(1,4,5)P3
bound to purified
aldolase
(at 0 degree C) in a dose-dependent manner over the range [
Ins(1,4,5)P3
] 20 nM to 20 microM, with maximal binding of 1 mol of
Ins(1,4,5)P3
/mol aldolase4 and a Kd of 12-14 microM. Fru(1,6)P2 and Fru(2,6)P2 displaced bound
Ins(1,4,5)P3
) with a 50% inhibition at 30 and 170 microM, respectively. Ins(1,3,4)P3 (20 microM) and glyceraldehyde 3-phosphate (2 mM) were also potent inhibitors of
Ins(1,4,5)P3
binding, but not inositol 4-phosphate or inositol 1,4-bisphosphate (20 microM each). Aldolase-bound
Ins(1,4,5)P3
may play a role in phospholipase C-independent increases in free [
Ins(1,4,5)P3
].
...
PMID:Inositol 1,4,5-trisphosphate binding to porcine tracheal smooth muscle aldolase. 765 22